Compositions and Methods of Treating Muscle Atrophy and Myotonic Dystrophy
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 10 of these applications claim priority to application PCT/US2018/064359, filed Dec 6, 2018. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,881,743 | Compositions and Methods of Treating Muscle Atrophy and Myotonic Dystrophy In force · Medium confidence UsedRemaining | Avidity Biosciences LLC | In force | Medium confidence | ||
| US 11,246,941 | Compositions and Methods of Treating Muscle Atrophy and Myotonic Dystrophy In force · Medium confidence | Avidity Biosciences, Inc. | In force | Medium confidence | ||
| US 11,253,607 | Compositions and Methods of Treating Muscle Atrophy and Myotonic Dystrophy In force · Medium confidence | Avidity Biosciences, Inc. | In force | Medium confidence | ||
| US 11,497,814 | Compositions and Methods of Treating Muscle Atrophy and Myotonic Dystrophy In force · Low confidence | Avidity Biosciences, Inc. | In force | Low confidence | ||
| US 11,554,176 | Compositions and Methods of Treating Muscle Atrophy and Myotonic Dystrophy In force · Low confidence | Avidity Biosciences, Inc. | In force | Low confidence | ||
| US 11,576,980 | Compositions and Methods of Treating Muscle Atrophy and Myotonic Dystrophy In force · Low confidence | Avidity Biosciences, Inc. | In force | Low confidence | ||
| US 11,583,591 | Compositions and Methods of Treating Muscle Atrophy and Myotonic Dystrophy In force · Low confidence | Avidity Biosciences, Inc. | In force | Low confidence | ||
| US 11,872,287 | Compositions and Methods of Treating Muscle Atrophy and Myotonic Dystrophy In force · Low confidence | Avidity Biosciences, Inc. | In force | Low confidence | ||
| US 12,263,224 | Compositions and Methods of Treating Muscle Atrophy and Myotonic Dystrophy In force · High confidence | Avidity Biosciences, Inc. | In force | High confidence | ||
| US 11,712,478 | Compositions and Methods of Treating Muscle Atrophy and Myotonic Dystrophy In force · Medium confidence | Avidity Biosciences, Inc. | In force | Medium confidence | ||
| 4 more records in this group · Pro | ||||||
10 of 14 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 14.
10 of these are in force and held by Avidity Biosciences, Inc..
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.